Page last updated: 2024-10-20

pyrazinamide and Chemical and Drug Induced Liver Injury, Chronic

pyrazinamide has been researched along with Chemical and Drug Induced Liver Injury, Chronic in 2 studies

pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.

Chemical and Drug Induced Liver Injury, Chronic: Liver disease lasting six months or more, caused by an adverse effect of a drug or chemical. The adverse effect may be caused by drugs, drug metabolites, chemicals from the environment, or an idiosyncratic response.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Wen, Y1
Zhang, G1
Wu, X1
Ezhilarasan, D1

Reviews

1 review available for pyrazinamide and Chemical and Drug Induced Liver Injury, Chronic

ArticleYear
Antitubercular drugs induced liver injury: an updated insight into molecular mechanisms.
    Drug metabolism reviews, 2023, Volume: 55, Issue:3

    Topics: Antitubercular Agents; Chemical and Drug Induced Liver Injury; Chemical and Drug Induced Liver Injur

2023

Other Studies

1 other study available for pyrazinamide and Chemical and Drug Induced Liver Injury, Chronic

ArticleYear
The role of the farnesoid X receptor in quadruple anti-tuberculosis drug-induced liver injury.
    Toxicology, 2022, 06-30, Volume: 476

    Topics: Animals; Antitubercular Agents; Bile Acids and Salts; Chemical and Drug Induced Liver Injury; Chemic

2022